Right, and a lot of what you talk about in your post is a big issue in the industry.
Consumers are always looking for the best deals (hence why priceplow is awesome). But in doing so, a lot of times they’ll buy cheaper brands that are using poor extracts.
So what happens is, people say ‘oh but I’ve tried Ashwagandha and it didn’t really do much, so why would I buy this more expensive Ashwagandha product’
Shitty products damage the mental perception of ingredients that have potential, and then you’re facing an even bigger uphill battle to sell something that has data demonstrating efficacy, that you know works, but that people have a negative perception of due to shitty versions of that ingredient being sold.
KSM-66 is expensive, Sensoril is expensive, and to be certain, companies can not just increase their MSRP/Wholesale price by the price difference between those and generic Ashwagandha, so they have to eat it in the margins to some extent.
I’m a data guy, I try to give people as much data to support ingredients and products or argue against ingredients/products as possible. To me paying $5 more for an Ashwagandha product using a full human studied dose of KSM-66 or Sensoril over a generic one is therefore a no-brainer. But it seems like that ends up being a hard sell when it comes down to actual retail dollars.
It’s especially hard for the non-engaged portion of consumers. That is, the people who aren’t talking on the forums. To joe consumer who goes to GNC or VS or BB or whichever retail storefront and looks for an ashwagandha product, they’re usually just looking for the better deal, so unless you can really catch them with an effective presentation of marketing data, it’s really hard to capture market share there. And that non-engaged portion of consumers represents the majority of supplement sales.